Caralluma Fimbriata
5 benefits mapped to clinical evidence across supplements.
Dose per serving from products
25 products in our catalogue print how much Caralluma Fimbriata a serving holds.
Most common: 1 g to 2.5 g, 60% of 25 products.
| Dose per serving | Products |
|---|---|
| 250 mg to 500 mg | 4 |
| 500 mg to 1 g | 6 |
| 1 g to 2.5 g | 15 |
Benefit Evidence
Research sources
Weight management (3)
- The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults
PubMed ID: 33762661
Direct measurement: CFE reduced caloric intake by ~245 kcal/day vs ~16 kcal/day in placebo (difference ≈ −229 kcal/day; p<0.01) over 16 weeks.
- A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial
PubMed ID: 23642949
12‑week pilot showed greater waist circumference reduction (−6.5 cm vs −2.6 cm; difference ≈ −3.85 cm, 95% CI nearly excluding zero) and improved WHR.
- Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women
PubMed ID: 17097761
60‑day trial reported a significant decline in waist circumference vs placebo.
Appetite suppression (2)
- Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women
PubMed ID: 17097761
Randomized trial (60 d, n=50) reported a significant decline in self‑reported hunger versus placebo.
- The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults
PubMed ID: 33762661
16‑week RCT documented a large reduction in daily caloric intake (−245 kcal/day vs −15.8 kcal/day; p<0.01), consistent with appetite suppression.
Satiety (2)
- Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women
PubMed ID: 17097761
Significant reduction in self‑reported hunger in a 60‑day RCT suggests increased satiety.
- The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults
PubMed ID: 33762661
Substantial reduction in daily calorie intake over 16 weeks implies greater satiety/less intake.
Body composition (2)
- The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults
PubMed ID: 33762661
16‑week RCT showed prevention of weight/BMI gain and reduced waist circumference, indicating favorable body composition effects.
- A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial
PubMed ID: 23642949
Pilot RCT showed meaningful reductions in waist circumference and WHR, indicating central body composition improvements.
Mood balance (1)
- A randomised placebo controlled clinical trial on the efficacy of Caralluma fimbriata supplement for reducing anxiety and stress in healthy adults over eight weeks
PubMed ID: 30609411
Well-powered (n=97) double‑blind RCT showed significantly greater reductions in anxiety (GAD‑7) and perceived stress (PSS) vs placebo at 4 and 8 weeks.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Caralluma Fimbriata
Search all37 products whose verified label declares Caralluma Fimbriata — not every bottle that mentions it in a title.